Investigation of Neuronal–Astroglial Injury Proteins and MMP‐9 Serum Levels in Autism Spectrum Disorder and Their Relationship With Autistic Regression
International Journal of Developmental Neuroscience · 2025
DOI: 10.1002/jdn.70005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2025. Verfasst von Huriye Berna Devecioğlu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Ankara Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Matrix Metalloproteinase 9, Astrocytes, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Hacettepe University Coordination Unit for Scientific Research Projects, Hacettepe Üniversitesi.
Abstract (Originalsprache)
Objective
This study compared serum levels of S100B, GFAP, UCHL‐1, NF‐H and MMP‐9 between children with Autism Spectrum Disorder (ASD) and controls, focusing on their association with regression in ASD. We hypothesized that neuroinflammation and neuronal/astroglial damage markers would be higher in the ASD group than in controls and even more elevated in the regressive ASD subgroup compared to the non‐regressive subgroup.
Methods
The study included 50 children with ASD (ages 4–10) and 30 healthy children. Participants underwent the K‐SADS‐PL diagnostic interview, CARS, a semi‐structured interview for regression, ABC, AuBC, CPRS‐RS and SRS assessments. Serum levels of S100B, GFAP, UCHL‐1, NF‐H and MMP‐9 were measured using flow cytometry and ELISA.
Results
Serum levels of S100B, GFAP, UCHL‐1, NF‐H and MMP‐9 showed no significant differences between the ASD and control groups. Within the ASD group, no notable differences were found in sociodemographic, clinical characteristics, or serum marker levels between those with and without regression.
Conclusion
The findings obtained in this study suggested that it is necessary to question whether the peripheral circulation can represent changes in central nervous system and to review the existence of autistic regression as a separate entity in ASD in terms of clinical features and etiopathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, Ankara Etlik City Hospital, Ankara, Turkey.
- Faculty of Medicine, Department of Immunology, Erciyes University, Kayseri, Turkey.
- Department of Child and Adolescent Psychiatry, Ankara Education and Research Hospital, Ankara, Turkey.
- Private Practice, Child and Adolescent Psychiatry, Ankara, Turkey.
- Faculty of Medicine, Department of Immunology, Hacettepe University, Ankara, Turkey.
ORCID-Profile: Huriye Berna Devecioğlu
Förderung
- Hacettepe University Coordination Unit for Scientific Research Projects
- Hacettepe Üniversitesi
Zitieren
APA
Devecioğlu, H. B., Tan, Ç., Mısır, E. G., Esen, H. T. Ç., Özbek, B., & Kültür, S. E. Ç. (2025). Investigation of Neuronal–Astroglial Injury Proteins and MMP‐9 Serum Levels in Autism Spectrum Disorder and Their Relationship With Autistic Regression. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.70005
Vancouver
Devecioğlu HB, Tan Ç, Mısır EG, Esen HTÇ, Özbek B, Kültür SEÇ. Investigation of Neuronal–Astroglial Injury Proteins and MMP‐9 Serum Levels in Autism Spectrum Disorder and Their Relationship With Autistic Regression. International Journal of Developmental Neuroscience. 2025. doi:10.1002/jdn.70005
BibTeX
@article{Deveciolu2025,
author = {Devecioğlu, Huriye Berna and Tan, Çağman and Mısır, Ekin Günal and Esen, Halime Tuna Çak and Özbek, Begüm and Kültür, Sadriye Ebru Çengel},
title = {Investigation of Neuronal–Astroglial Injury Proteins and MMP‐9 Serum Levels in Autism Spectrum Disorder and Their Relationship With Autistic Regression},
journal = {International Journal of Developmental Neuroscience},
year = {2025},
doi = {10.1002/jdn.70005}
}
EUVIMED